Altered response to adaptive signals in transplanted intestine
Jon S. Thompson(Nebraska Medical Center), Debra C. Ferguson(AbbVie (United States))
Cited by 0
Related Papers
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
|Nature|2017|878
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models
|Clinical Cancer Research|2007|776
Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models
|Clinical Cancer Research|2008|211